ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY

Detaylı Bibliyografya
Asıl Yazarlar:	Collin, S, Metcalfe, C, Donovan, J, Lane, J, Neal, D, Hamdy, F, Davis, M, Martin, R
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2009

Benzer Materyaller

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
Yazar:: Turner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
Yazar:: Neal, D, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
Yazar:: Brindle, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Yazar:: Macefield, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
Yazar:: Zuccolo, L, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
Yazar:: Moore, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study
Yazar:: Dimitropoulou, P, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study.
Yazar:: Dimitropoulou, P, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Screening for prostate cancer. The case against.
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Prostate cancer: screening approaches.
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Prostate cancer: screening approaches
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

10-year outcomes in localized prostate cancer.
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study
Yazar:: Leal, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Screening for prostate cancer remains controversial.
Yazar:: Neal, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

10-year outcomes in localized prostate cancer: Authors' reply
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

PTGS2-899G>C and prostate cancer risk: a population-based nested case-control study (ProtecT) and a systematic review with meta-analysis.
Yazar:: Murad, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
Yazar:: Burton, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Yazar:: Harrison, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.
Yazar:: Macefield, R, ve diğerleri
Baskı/Yayın Bilgisi: (2010)